Kaneka Corporation   Report issue

For profit Phase 1 Phase 2
Founded: Osaka Japan (1949)
Status: No NME R&D (1949)

Organization Overview

First Clinical Trial
2009
NCT00980694
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kaneka Americas Holding Inc. | Kaneka Corporation | Kaneka Pharma America LLC